PDS Biotechnology Corp Weighted Average Number of Shares Outstanding, Basic and Diluted
PDS Biotechnology Corp (PDSB) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 16.75 million shares for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-18.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2021-03-18
- PDS Biotechnology Corp weighted average number of shares outstanding, basic and diluted for the quarter ending 2020-12-31 was 22.30M shares, a 322.00% increase year-over-year.
- PDS Biotechnology Corp weighted average number of shares outstanding, basic and diluted for the quarter ending 2020-09-30 was 18.96M shares, a 261.39% increase year-over-year.
- PDS Biotechnology Corp weighted average number of shares outstanding, basic and diluted for the quarter ending 2019-12-31 was 5.28M shares, a 47.20% increase year-over-year.
- PDS Biotechnology Corp weighted average number of shares outstanding, basic and diluted for the quarter ending 2019-09-30 was 5.25M shares, a 56.80% increase year-over-year.
- PDS Biotechnology Corp weighted average number of shares outstanding, basic and diluted for fiscal 2020 was 16.75M shares, a 243.98% increase from fiscal 2019.
- PDS Biotechnology Corp weighted average number of shares outstanding, basic and diluted for fiscal 2019 was 4.87M shares, a 45.87% increase from fiscal 2018.
- PDS Biotechnology Corp weighted average number of shares outstanding, basic and diluted for fiscal 2018 was 3.34M shares, a 89.02% decline from fiscal 2017.
- PDS Biotechnology Corp weighted average number of shares outstanding, basic and diluted for fiscal 2017 was 30.39M shares, a 5.30% increase from fiscal 2016.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2020-12-31 | 22.30M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | 20.63M shares derived: average of 2 quarters · filed 2021-03-18 | 16.75M shares 10-K · filed 2021-03-18 | ||||
| 2020-09-30 | 18.96M shares 10-Q · filed 2020-11-13 | 14.89M shares 10-Q · filed 2020-11-13 | |||||
| 2019-12-31 | 5.28M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | 5.27M shares derived: average of 2 quarters · filed 2021-03-18 | 4.87M shares 10-K · filed 2021-03-18 | ||||
| 2019-09-30 | 5.25M shares 10-Q · filed 2020-11-13 | 4.73M shares 10-Q · filed 2020-11-13 | |||||
| 2018-12-31 | 3.59M shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27 | 3.47M shares derived: average of 2 quarters · filed 2020-03-27 | 12.74M shares derived: average of 3 quarters · filed 2020-03-27 | 3.34M shares 10-K · filed 2020-03-27 | 31.24M shares 10-K · filed 2019-02-21 | ||
| 2018-09-30 | 3.35M shares 10-Q · filed 2019-11-07 | 31.33M shares 10-Q · filed 2018-11-01 | 17.32M shares derived: average of 2 quarters · filed 2019-11-07 | 3.25M shares 10-Q · filed 2019-11-07 | 31.20M shares 10-Q · filed 2018-11-01 | 24.23M shares derived: average of 4 quarters · filed 2019-11-07 | |
| 2018-06-30 | 31.30M shares 10-Q · filed 2018-08-01 | 31.13M shares 10-Q · filed 2018-08-01 | 31.19M shares derived: average of 3 quarters · filed 2019-02-21 | 31.10M shares derived: average of 4 quarters · filed 2019-02-21 | |||
| 2018-03-31 | 30.97M shares 10-Q · filed 2018-05-01 | 31.13M shares derived: average of 2 quarters · filed 2019-02-21 | 31.04M shares derived: average of 3 quarters · filed 2019-02-21 | 30.88M shares derived: average of 4 quarters · filed 2019-02-21 | |||
| 2017-12-31 | 31.30M shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-21 | 31.08M shares derived: average of 2 quarters · filed 2019-02-21 | 30.85M shares derived: average of 3 quarters · filed 2019-02-21 | 30.39M shares 10-K · filed 2019-02-21 | |||
| 2017-09-30 | 30.85M shares 10-Q · filed 2018-11-01 | 30.63M shares derived: average of 2 quarters · filed 2018-11-01 | 30.09M shares 10-Q · filed 2018-11-01 | 29.79M shares derived: average of 4 quarters · filed 2018-11-01 | |||
| 2017-06-30 | 30.40M shares 10-Q · filed 2018-08-01 | 29.70M shares 10-Q · filed 2018-08-01 | 29.44M shares derived: average of 3 quarters · filed 2018-08-01 | 29.30M shares derived: average of 4 quarters · filed 2018-08-01 | |||
| 2017-03-31 | 29.00M shares 10-Q · filed 2018-05-01 | 28.95M shares derived: average of 2 quarters · filed 2018-05-01 | 28.94M shares derived: average of 3 quarters · filed 2018-05-01 | 28.91M shares derived: average of 4 quarters · filed 2018-05-01 | |||
| 2016-12-31 | 28.91M shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | 28.90M shares derived: average of 2 quarters · filed 2018-03-01 | 28.88M shares derived: average of 3 quarters · filed 2018-03-01 | 28.86M shares 10-K · filed 2018-03-01 | |||
| 2016-09-30 | 28.90M shares 10-Q · filed 2017-11-01 | 28.86M shares derived: average of 2 quarters · filed 2017-11-01 | 28.85M shares 10-Q · filed 2017-11-01 | 28.46M shares derived: average of 4 quarters · filed 2018-03-01 | |||
| 2016-06-30 | 28.83M shares 10-Q · filed 2017-08-01 | 28.82M shares 10-Q · filed 2017-08-01 | 28.31M shares derived: average of 3 quarters · filed 2018-03-01 | 21.65M shares derived: average of 4 quarters · filed 2018-03-01 | |||
| 2016-03-31 | 28.81M shares 10-Q · filed 2017-05-03 | 28.05M shares derived: average of 2 quarters · filed 2018-03-01 | 19.26M shares derived: average of 3 quarters · filed 2018-03-01 | 14.87M shares derived: average of 4 quarters · filed 2018-03-01 | |||
| 2015-12-31 | 27.29M shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | 14.49M shares derived: average of 2 quarters · filed 2018-03-01 | 10.22M shares derived: average of 3 quarters · filed 2018-03-01 | 8.09M shares 10-K · filed 2018-03-01 | |||
| 2015-09-30 | 1.69M shares 10-Q · filed 2016-11-01 | 1.69M shares derived: average of 2 quarters · filed 2016-11-01 | 1.69M shares 10-Q · filed 2016-11-01 | 1.69M shares derived: average of 4 quarters · filed 2017-03-02 | |||
| 2015-06-30 | 1.69M shares 10-Q · filed 2016-08-03 | 1.69M shares 10-Q · filed 2016-08-03 | 1.69M shares derived: average of 3 quarters · filed 2017-03-02 | 1.69M shares derived: average of 4 quarters · filed 2017-03-02 | |||
| 2015-03-31 | 1.69M shares 10-Q · filed 2016-05-03 | 1.69M shares derived: average of 2 quarters · filed 2017-03-02 | 1.69M shares derived: average of 3 quarters · filed 2017-03-02 | ||||
| 2014-12-31 | 1.69M shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-02 | 1.69M shares derived: average of 2 quarters · filed 2017-03-02 | 1.69M shares 10-K · filed 2017-03-02 | ||||
| 2014-09-30 | 1.69M shares 10-Q · filed 2015-11-06 | 1.69M shares 10-Q · filed 2015-11-06 | |||||
| 2013-12-31 | 1.69M shares 10-K · filed 2016-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |